© 2022 Cerebral Inc. All rights reserved.
By clicking “Request to Join!”, you agree to Cerebral’s Terms & Conditions , including the mandatory arbitration provision, Privacy Policy and Telehealth Consent..
Telehealth provider Cerebral is partnering with Alto Neuroscience to lead a clinical study evaluating an investigational treatment for depression. Qualifying participants in Atlanta, Dallas, LA, or NYC metro areas may receive study-related medical care at no cost, up to $575 in compensation for their time, a wearable health and fitness tracker, and a complimentary Cerebral subscription for the duration of the study. Fill out the clinical research pre-screening survey to determine if you qualify!
Join a clinical study for an investigational antidepressant medication
If eligible, you get:
You may be eligible if (read more below):
Participate in a compensated depression study
You must:
You must not:
Any other questions?
Connect with a clinical research coordinator by calling customer support at (415) 458 - 2667, or email clinicaltrials@cerebral.com.
What is included in this study?
This clinical study will run for 11 weeks, including 7 remote visits and 2 in-person visits (completed directly in your home or in another private location such as a friend or family member's home). Most visits will take approximately 1 hour of your time, although several may last up to 2 to 3 hours. For at-home visits, study staff will be fully vaccinated against COVID-19 and will wear masks for the entire visit.
What is a "Clinical Study"?
Clinical studies enable new medications and treatments to be approved for broader use.
They are highly organized and regulated to see if new treatments work safely. Millions of lives can benefit from the success of a study thanks to volunteers like you.
By signing up you agree to receive text messages and emails about this study. Text messages and data rates may apply. You can unsubscribe at any time.